Drug Topics March 19, 2025
A recent study found that continuous glucose monitors could help improve patient comfort, reduce resource use, and improve outcomes.
Patients with diabetic ketoacidosis (DKA) can benefit from using a continuous glucose monitor (CGM) due to their ability to provide accurate blood glucose measurements and identify missed opportunities for earlier intervention, according to data published in the journal CHEST Critical Care.1 Authors of the study said that future trials should assess the impact of CGM on patient outcomes, experiences, and resource use.
DKA is a life-threatening complication of diabetes and is typically seen in patients with type 1 diabetes (T1D).2 There are numerous triggers for DKA, including new-onset diabetes, infections, or lack of compliance with treatment. Although the mortality rate of...
Today's Sponsors
Today's Sponsor